Intelligence · Clinical Development
Pipeline search results
Programs matching “aflibercept” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 79 pipeline programs matching "aflibercept" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Prompt aflibercept
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
Prompt aflibercept
Regeneron UK Limited
Diabetic Retinopathy
1 trial -
aflibercept
Regeneron UK Limited
Retinopathy of Prematurity
1 trial -
aflibercept 8 mg PFS
Regeneron UK Limited
Diabetic Macular Edema (DME)
1 trial -
ARD6122
Regeneron UK Limited
Neoplasms
1 trial -
ARD6123
Regeneron UK Limited
Pulmonary Diseases
1 trial -
Aflibercept
Regeneron UK Limited
Radiation Retinopathy
1 trial -
Aflibercept
Regeneron UK Limited
Advanced Carcinoma
1 trial -
Aflibercept
Regeneron UK Limited
Proliferative Diabetic Retinopathy
1 trial -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Diabetic Macular Edema
1 trial -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Central Retinal Vein Occlusion
1 trial -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Central Serous Chorioretinopathy
1 trial -
Intravitreal Aflibercept Injection
Regeneron UK Limited
Age-Related Macular Degeneration
2 trials -
Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
Regeneron UK Limited
Thyroid Eye Disease
1 trial -
VGFT-OD-0508
Regeneron UK Limited
Macular Degeneration
1 trial -
ZIV-Aflibercept
Regeneron UK Limited
Metastatic Uveal Melanoma
1 trial -
Ziv-Aflibercept
Regeneron UK Limited
Uveal Melanoma
1 trial -
aflibercept
Regeneron UK Limited
Neovascular (Wet) Age-Related Macular Degeneration
1 trial -
aflibercept + FOLFIRI
Regeneron UK Limited
Metastatic Colorectal Cancer
1 trial -
AVE0005 (aflibercept)
Regeneron UK Limited
Colorectal Neoplasms
1 trial -
Aflibercept
Regeneron UK Limited
Irvine-Gass Syndrome
1 trial -
Aflibercept
Regeneron UK Limited
Neovascular Macular Degeneration
1 trial -
Aflibercept (AVE0005)
Regeneron UK Limited
Neoplasm Malignant
2 trials -
Aflibercept every 2 months
Regeneron UK Limited
Radiation Retinopathy
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.